About the name
Cerenovus Inc. — this company, at cerenovus.ai — is an artificial intelligence software company in San Francisco, founded in 2026 and backed by Y Combinator (Summer 2026). We build an AI operating partner for large enterprises.
CERENOVUS — the other one — is a neurovascular medical-device business in Irvine, California, owned by Johnson & Johnson. It makes devices used to treat stroke. We are not affiliated with it, we are not a spin-out of it, and we have no connection to Johnson & Johnson.
No. Cerenovus Inc. is an independent artificial-intelligence software company founded in 2026 and based in San Francisco, California, backed by Y Combinator in its Summer 2026 batch. It has no ownership, commercial, or historical connection to Johnson & Johnson.
CERENOVUS is a neurovascular medical-device business headquartered in Irvine, California, and owned by Johnson & Johnson. It makes devices used in the endovascular treatment of ischemic and hemorrhagic stroke. It was formed in 2017 from the Neuravi and Pulsar Vascular acquisitions.
It helps large enterprises make better operating decisions. It reads the records an organization already produces — email, contracts, ledgers, tickets, documents and meeting notes — surfaces the problems and inefficiencies buried in them, and puts each finding in front of the people who have to decide, cited to the source record behind it.
The AI software company is at cerenovus.ai and is usually written "Cerenovus AI". The medical-device business is written in capitals as CERENOVUS and appears under jnjmedtech.com. If the context is stroke treatment, catheters or stent retrievers, it is the Johnson & Johnson business, not us.
Looking for what we build? How Cerenovus works · Solutions · Book a demo